AMNEAL PHARMACT Stock Price (NYSE:AMRX)

Add to My Stocks
$18.84 $0.69 (3.53%) AMRX stock closing price Jun 19, 2018 (Closing)
Prev Close* : $19.53
Market Cap:
$1.44B
Day Low: $18.71
52 Week Low: $13.25
Open: $19.43
Volume: -
Day High: $19.59
52 Week High: $25.70
Dividend:
0.00

Latest Stock Market News

Latest Articles

AMNEAL PHARMACT News - From Partners

AMRX Stockcharts

View AMRX PE ratio, PS ratio stocks charts and compare with peers.
AMRX Chart
Note: Compare AMNEAL PHARMACT stock price history with the index and industry peers.

AMNEAL PHARMACT Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
1.85
PB ratio (
price to book ratio
)
3.78

AMNEAL PHARMACT Returns

ROE
(return on equity)
-140%

AMNEAL PHARMACT Financial Ratios

Asset Turnover
0.44
Receivables Turnover
2.88
Debt to Equity
13.24
Dividend Yield
0%

AMRX Industry Peers

Company Price Change (%)
Pacira Pharma (PCRX)38.050.85 (2.28%)
Therapeuticsmd (TXMD)7.180.02 (0.28%)
Radius Health (RDUS)31.310.63 (2.05%)
Immunogen (IMGN)10.50.17 (1.65%)
Lipocine (LPCN)1.340 (0%)
Astrazeneca (AZN)35.940.16 (0.44%)
Perrigo (PRGO)75.641.28 (1.72%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)3.230.78 (31.84%)
Galmed Pharma (GLMD)15.690.78 (5.23%)
Synergy Pharma (SGYP)1.890.08 (4.42%)
Achaogen (AKAO)12.210.5 (4.27%)
BioCryst Pharma (BCRX)5.970.2 (3.47%)
Portola Pharma (PTLA)42.771.36 (3.28%)
Endo International (ENDP)9.440.29 (3.17%)
Top gainers from Medical-Drugs industry
* As of Jun 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)33.2414.64 (30.58%)
CORREVIO PHARMA (CORV)3.680.22 (5.64%)
Corcept Therapeutics (CORT)16.2750.61 (3.61%)
Redhill Biopharma (RDHL)7.90.29 (3.54%)
AMNEAL PHARMACT (AMRX)18.840.69 (3.53%)
Nature's Sunshine Products (NATR)8.60.3 (3.37%)
Durect (DRRX)2.10.07 (3.23%)
Top losers from Medical-Drugs industry
* As of Jun 20, 2018

AMNEAL PHARMACT Financial Statements

income statement20172016201520142013
Net Sales or Revenues775.78M824.42M860.46M596.04M511.5M
Net Income-469.28M-472.03M38.99M57.35M101.25M
Total Operating Expense546.48M343.07M282.83M223.83M205.68M
View AMNEAL PHARMACT income statement
balance sheet20172016201520142013
Total Assets1.35B1.82B1.92B1.08B996.92M
Total Liabilities1.16B1.2B860.07M191.32M186.72M
Shareholders Equity187.2M623.97M1.06B887.87M810.2M
View AMNEAL PHARMACT balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-11.11M-2.43M-70.18M-76.23M-11.04M
Net Cash from (used by) Operating Activities84.22M74.59M71.92M32.81M149.94M
Increase (Decrease) in Prop Plant And Equipment-17.63M-48.04M-25.19M-29.91M-32.78M
View AMNEAL PHARMACT cash flow statement

AMNEAL PHARMACT Stock Message Board